Headline News about Veracyte Inc
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/08/11/NYSE-Bell-Podium-OB-Photo-200922-4-002.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/07/VCYT.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/07/Shopify_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Recap: Veracyte Q4 Earnings
February 22, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Veracyte
February 21, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Veracyte: Q3 Earnings Insights
November 07, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2021/10/health-wellness-exercise-1600.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Veracyte
October 20, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/733060/a-person-speaks-to-their-doctor.jpg)
![](/next-assets/images/schema-image-default.png)
Looking Into Veracyte's Return On Capital Employed
May 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/10/Cathie-Wood--founder-of-Ark-Invest-.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Cathie-Wood-Bitcoin_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Cathie-Wood_4.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/cathie-wood-bitcoin_5.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie-Wood-Ark-Invest_3.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/09/undervalued-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/04/medicines-661612_1280.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/746165/a-doctor-examines-a-patient.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.